ホーム › 血液がん › コロンビア特別区 › Washington
Washington、DCにおける血液がんの臨床試験
Washingtonとその周辺地域（約30マイル以内）の拠点で、血液がんに関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
被験者募集中第1相
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7マイル先
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
被験者募集中第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
被験者募集中第1/2相健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
被験者募集中第3相
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7マイル先
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
被験者募集中第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
被験者募集中第1/2相健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Longitudinal Studies of Patient With FPDMM
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
被験者募集中第1/2相健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
被験者募集中観察研究
- The Center for Cancer and Blood Disorders, Bethesda · 7マイル先
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
被験者募集中第1相
- Childrens National Medical Center, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
被験者募集中
- Georgetown University School of Medicine, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 7マイル先
- Nih/Nhlbi, Bethesda · 7マイル先
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
被験者募集中第1/2相
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7マイル先
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
被験者募集中第1/2相健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
被験者募集中観察研究
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
被験者募集中第1相
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · 7マイル先
他の都市における血液がんの試験
- Houston, TX46件の研究
- New York City, NY26件の研究
- Boston, MA25件の研究
- Seattle, WA18件の研究
- Baltimore, MD18件の研究
- Los Angeles, CA17件の研究
- Durham, NC16件の研究
- Chicago, IL15件の研究
- Philadelphia, PA14件の研究
- Nashville, TN13件の研究
- Columbus, OH13件の研究
- Edison, NJ13件の研究
Washingtonにおける他の研究
- がん（全種類）58件の研究
- 非小細胞肺癌55件の研究
- 乳がん46件の研究
- 転移性癌43件の研究
- 肺がん41件の研究
- 前立腺がん38件の研究
- 肥満症33件の研究
- 大腸癌29件の研究
- 心血管疾患28件の研究
- 膀胱癌26件の研究
- 急性骨髄性白血病24件の研究
- 卵巣がん23件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。